Premium
Real‐world efficacy and safety of dividing aflibercept into three syringes in the treatment of wet age‐related macular degeneration
Author(s) -
Hujanen Pekko,
Tuulonen Anja,
UusitaloJärvinen Hannele
Publication year - 2019
Publication title -
acta ophthalmologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.534
H-Index - 87
eISSN - 1755-3768
pISSN - 1755-375X
DOI - 10.1111/aos.14051
Subject(s) - aflibercept , ranibizumab , macular degeneration , medicine , bevacizumab , ophthalmology , health care , optometry , surgery , chemotherapy , economics , economic growth
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom